Hemodynamic Changes With Passive Leg Raising Maneuver in Patients Undergoing Arthroscopic Shoulder Surgery

Arthroscopic Shoulder Surgery Clinical Trial

Official title:

Evaluation of Volume Status by Passive Leg Removal Maneuver and Vena Cava Inferior Diameter Measurements Before the Position of Patients in Arthroscopic Shoulder Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04152135
• Other study ID #: 1
• Status: Not yet recruiting
• Start date: November 29, 2019
• Est. completion date: September 1, 2020

Study information

• Verified date: November 2019
• Source: Diskapi Teaching and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

After intubation of the patients who are undergoing arthroscopic shoulder surgery, plethysmographic waveform will be recorded with blood pressure, heart rate and end-tidal carbon dioxide values and inferior vena cava (IVC) diameter will be measured by ultrasound. New hemodynamic values will be measured after passive leg raising maneuver. Blood pressure, heart rate, end-tidal carbon dioxide values will be re-measured and plethysmographic waveform will be recorded after beach chair position for surgery.

Description:

Patients aged between 18-65 years who are undergoing arthroscopic shoulder surgery will be examined. After giving detailed information, voluntary certificate will be taken from patients who accept to participate in the study. Heart rate, oxygen saturation and blood pressure values will be recorded by routine monitoring. After intubation of the patients, plethysmographic waveform will be recorded with blood pressure, heart rate and end-tidal carbon dioxide values and IVC diameter will be measured by ultrasound. New hemodynamic values will be measured after passive leg raising maneuver. Blood pressure, heart rate, end-tidal carbon dioxide values will be re-measured and plethysmographic waveform will be recorded after beach chair position for surgery.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: September 1, 2020
• Est. primary completion date: August 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 years old patients,

• The American Society of Anesthesiologists (ASA) physical status classification score 1-2,

• Patients scheduled for arthroscopic shoulder surgery, intubated, sitting position

Exclusion Criteria:

• Patient refusal,

• Patients with current heart and valve disease,

• Patients with ASA 3-4 status,

• Emergency cases

Related Conditions & MeSH terms

• Arthroscopic Shoulder Surgery

Intervention

Procedure:
• vena cava inferior diameter measurement
Ultrasound equipment with convex probe will be used to measure IVC diameters of the patients in supine position.The IVC sagittal section is described with the probe in the area of subxiphoid. IVC diameters at the junction point of the IVC and right atrium (2cm caudal) are standardized measurement.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Diskapi Teaching and Research Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	passive leg raising maneuver	Head of bed at 0 degrees flat and both legs elevated to 45 degrees	2 minutes
Primary	vena cava inferior diameter	Ultrasound equipment with convex probe will be used to measure IVC diameters of the patients in supine position.The IVC sagittal section is described with the probe in the area of subxiphoid. IVC diameters at the junction point of the IVC and right atrium (2cm caudal) are standardized measurement.	2 minutes
Secondary	Blood pressure	non-invasive measurement, routine monitoring	2 minutes
Secondary	Heart rate	Routine monitoring	2 minutes
Secondary	End-tidal CO2	Routine monitoring after intubation	2 minutes
Secondary	plethysmographic waveform	Routine monitoring	2 minutes